You have 9 free searches left this month | for more free features.

HSV-2

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)

Not yet recruiting
  • Herpes Simplex
  • HSVTI Formulation 1
  • +2 more
  • Tokyo, Japan
    GSK Investigational Site
Aug 4, 2023

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Suspended
  • HSV-2 Infection
  • Herpes Simplex Virus Infection
  • Diagnostic Test: NOWDx HSV-2 Test
  • Tempe, Arizona
  • +2 more
Sep 29, 2022

Herpes Simplex 2, Meningitis, Viral Trial (Acyclovir 50 MG/ML, Placebo)

Not yet recruiting
  • Herpes Simplex 2
  • Meningitis, Viral
  • Acyclovir 50 MG/ML
  • Placebo
  • (no location specified)
Jul 11, 2022

Recurrent Genital Herpes Trial (UB-621)

Not yet recruiting
  • Recurrent Genital Herpes
  • UB-621
  • (no location specified)
May 16, 2022

Genital Herpes Trial in United States (mRNA-1608, BEXSERO)

Recruiting
  • Genital Herpes
  • mRNA-1608
  • BEXSERO
  • Birmingham, Alabama
  • +24 more
Sep 11, 2023

Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)

Not yet recruiting
  • Genital Herpes Simplex Type 2
  • BNT163
  • Placebo
  • (no location specified)
Jun 21, 2022

Advanced Colorectal Carcinoma Trial in Beijing (OH2, Capecitabine, Bevacizumab)

Not yet recruiting
  • Advanced Colorectal Carcinoma
  • OH2
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jan 28, 2023

HSV Trial (Pritelivir)

Available
  • HSV
  • (no location specified)
Apr 25, 2023

Genital Herpes Trial in Seattle (acyclovir, valacyclovir)

Completed
  • Genital Herpes
  • Seattle, Washington
    University of Washington Virology Research Clinic
Nov 16, 2021

Herpes Simplex Trial in Lenexa, Rochester (Lower dose formulation of HSV vaccine (GSK4108771A), Low dose formulation of HSV

Terminated
  • Herpes Simplex
  • Lower dose formulation of HSV vaccine (GSK4108771A)
  • +4 more
  • Lenexa, Kansas
  • +1 more
Jun 24, 2021

HSV-2 Trial in United States (AIC316, Placebo)

Completed
  • HSV-2
  • Miami, Florida
  • +5 more
Jan 6, 2022

Recurrent Genital Herpes Trial (Placebo, UB-621 low-dose, UB-621 high-dose)

Not yet recruiting
  • Recurrent Genital Herpes
  • Placebo
  • +2 more
  • (no location specified)
Jul 19, 2021

Options for Genital Herpes Infection to Reduce Adverse Pregnancy

Completed
  • HSV-2 Infection
  • +2 more
    • Oakland, California
      Division of Research
    Aug 23, 2021

    Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

    Not yet recruiting
    • Melanoma Stage IV
    • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
    • +2 more
    • (no location specified)
    Sep 27, 2021

    Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

    Not yet recruiting
    • Melanoma Stage IV
    • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
    • +2 more
    • (no location specified)
    Sep 27, 2021

    Autosomal Recessive Ichthyosis Trial in Rancho Santa Margarita (KB105, Placebo)

    Not yet recruiting
    • Autosomal Recessive Ichthyosis
    • KB105
    • Placebo
    • Rancho Santa Margarita, California
      Mission Dermatology
    Feb 20, 2023

    HSV Infection Trial in Cincinnati (Pritelivir, ESO and pritelivir)

    Completed
    • HSV Infection
    • Cincinnati, Ohio
      Medpace Clinical Pharmacology
    Aug 22, 2022

    Hepatocellular Carcinoma, Metastatic Cancer Trial in Makati City, Pasig City, Quezon City (GEN2 (HSV-Thymidine Kinase-m2 and

    Recruiting
    • Hepatocellular Carcinoma
    • Metastatic Cancer
    • GEN2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes)
    • Makati City, Philippines
    • +3 more
    Mar 14, 2022

    Immunogenetic Modulators of Mucosal Protection From HIV-1

    Completed
    • HIV Infections
    • HSV-2 Infection
      • Thika, Kenya
        Partners in Health, Research and Development
      Nov 2, 2020

      Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

      Recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +13 more
      • San Francisco, California
        University of California, San Francisco
      Jan 6, 2023

      Herpes Labialis, HSV Trial in Doral, Saint Paul (Squaric Acid Dibutyl Ester)

      Terminated
      • Herpes Labialis
      • HSV
      • Squaric Acid Dibutyl Ester
      • Doral, Florida
      • +1 more
      Aug 4, 2021

      Severe Herpes Simplex Infection by Valacyclovir and Interferon

      Completed
      • Herpes
      • +4 more
      • Moscow, Russian Federation
        Scientific Information Center for Prevention and Treatment of Vi
      Dec 5, 2020

      Genital Herpes Trial in Seattle (acyclovir)

      Terminated
      • Genital Herpes
      • Seattle, Washington
        University of Washington Virology Research Clinic
      Jan 16, 2020

      Frequency of Symptomatic Herpes Virus I and II in HIV Infected

      Recruiting
      • HIV Disease
      • +2 more
      • Blood draw
      • Los Angeles, California
        Global Research Institute
      Apr 9, 2023

      Sentosa SA HSV1/2 Qualitative PCR Test

      Completed
      • Herpes Simplex
      • Vela Sentosa SA HSV1/2 Qualitative PCR Test
      • Tampa, Florida
      • +8 more
      May 18, 2020